(b)(4).
Further information regarding event, product, or patient details has been requested.
No additional information is available at this time.
The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.
The filler was injected into the patient and is not accessible for return.
The syringe was not returned for evaluation.
A review of the device history record has been initiated.
If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.
This is a known potential adverse event addressed in the product labeling.
|
Healthcare professional reports patient injected with 1 ml of juvéderm® volbella¿ with lidocaine in the dark circles.
Injection site confirmed to be "asepsis" prior to injection.
During injection, tyndall effect and granulomas formed that did not improve with manual massage.
No report of biopsy of granulomas to confirm.
The next morning, patient presented with edema at the injection site with granulomas and tyndall effect persists.
The surrounding area was swollen and bluish.
Event ongoing.
|